We are live on
!
Find out more
SEI Investments Portfolio holdings
AUM
$108B
1-Year Est. Return
26.14%
This Fund
S&P 500
This Quarter
Est. Return
-13.05%
1 Year Est. Return
+26.14%
3 Year Est. Return
+80.41%
5 Year Est. Return
+95.44%
10 Year Est. Return
+382.16%
AUM
$28.1B
AUM Growth
+$498M
(+1.8%)
Cap. Flow
+$1.49B
Cap. Flow
% of AUM
5.3%
Top 10 Holdings %
Top 10 Hldgs %
17.84%
Holding
2,693
New
180
Increased
1,363
Reduced
436
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHV
Schwab US Large-Cap Value ETF
SCHV
|
+$72.2M |
| 2 |
Microsoft
MSFT
|
+$65.3M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$57.6M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$52.9M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$40.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Value ETF
VTV
|
+$60.3M |
| 2 |
Vanguard Total Bond Market
BND
|
+$43.2M |
| 3 |
Vanguard Growth ETF
VUG
|
+$40.1M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$28M |
| 5 |
AET
Aetna Inc
AET
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.26% |
| 2 | Financials | 12.3% |
| 3 | Healthcare | 10.62% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Vertex Pharmaceuticals
VRTX
$124B
| $25.5M | 0.09% |
134,806
+14,351
| +12% | +$2.49M |
|
227
Accenture
ACN
$101B
| $25.3M | 0.09% |
162,907
+66,341
| +69% | +$10.5M |
|
228
Kinder Morgan
KMI
$70.7B
| $25.3M | 0.09% |
1,444,051
+74,535
| +5% | +$1.26M |
|
229
ASE Group
ASX
$73.8B
| $25M | 0.09% |
5,235,904
+53,935
| +1% | +$214K |
|
230
Expedia Group
EXPE
$35.1B
| $24.7M | 0.09% |
193,319
+27,794
| +17% | +$3.33M |
|
231
L3Harris
LHX
$56.5B
| $24.5M | 0.09% |
154,886
+48,145
| +45% | +$7.27M |
|
232
Infosys
INFY
$49.7B
| $24.5M | 0.09% |
2,412,172
+131
| +0% | +$1.25K |
|
233
Paycom
PAYC
$7.56B
| $24.2M | 0.09% |
156,251
+1,055
| +0.7% | +$135K |
|
234
Vulcan Materials
VMC
$37.4B
| $24.2M | 0.09% |
231,367
+20,451
| +10% | +$2.07M |
|
235
Altria Group
MO
$125B
| $24M | 0.09% |
435,608
+54,204
| +14% | +$3.14M |
|
|
DNKN
236
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $23.9M | 0.09% |
325,546
+845
| +0.3% | +$60.1K |
|
237
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.1B
| $23.7M | 0.08% |
845,256
+840,988
| +19,704% | +$23.4M |
|
238
Ameriprise Financial
AMP
$48.5B
| $23.3M | 0.08% |
165,076
+6,302
| +4% | +$791K |
|
|
SPLK
239
DELISTED
Splunk Inc
SPLK
| $23.3M | 0.08% |
192,706
+1,021
| +0.5% | +$103K |
|
240
Micron Technology
MU
$920B
| $23.1M | 0.08% |
534,242
+70,969
| +15% | +$2.69M |
|
241
Extra Space Storage
EXR
$32B
| $22.9M | 0.08% |
264,583
+96
| +0% | +$8.73K |
|
|
EPAY
242
DELISTED
Bottomline Technologies Inc
EPAY
| $22.9M | 0.08% |
316,502
+2,153
| +0.7% | +$125K |
|
|
IPG
243
DELISTED
Interpublic Group of Companies
IPG
| $22.9M | 0.08% |
1,005,945
+59,623
| +6% | +$1.36M |
|
244
Credicorp
BAP
$30.9B
| $22.9M | 0.08% |
102,473
+282
| +0.3% | +$62.3K |
|
245
Morgan Stanley
MS
$333B
| $22.6M | 0.08% |
490,947
+17,957
| +4% | +$784K |
|
246
Gilead Sciences
GILD
$167B
| $22.6M | 0.08% |
304,310
+43,986
| +17% | +$3.07M |
|
247
Molina Healthcare
MOH
$10.3B
| $22.6M | 0.08% |
154,872
-413
| -0.3% | -$54.1K |
|
248
Graco
GGG
$13.3B
| $22.6M | 0.08% |
491,626
+19,783
| +4% | +$827K |
|
249
Truist Financial
TFC
$64.4B
| $22.5M | 0.08% |
465,758
+1,326
| +0.3% | +$63.7K |
|
250
Packaging Corp of America
PKG
$22.6B
| $22.5M | 0.08% |
246,816
+60,677
| +33% | +$5.64M |
|
Similar funds
SEI Investments's Q4 2018 Portfolio in Review
As of Q4 2018, SEI Investments held 2,693 positions worth $28.1B, up 1.8% from $27.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
SEI Investments deployed $1.49B of net new capital in Q4 2018, opening 180 new positions and adding to 1,363 existing holdings. Its largest new stake was Takeda Pharmaceutical: 288,231 shares worth $4.88M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Value ETF, an estimated $60.3M trimmed.
- SEI Investments's largest Q4 2018 buy was Takeda Pharmaceutical: 288,231 shares worth $4.88M.
- SEI Investments added most to Schwab US Large-Cap Value ETF in Q4 2018, an estimated $72.2M increase.
- SEI Investments's biggest Q4 2018 reduction was Vanguard Value ETF, cutting an estimated $60.3M.
- SEI Investments fully exited Invesco S&P International Developed Low Volatility ETF in Q4 2018, selling an estimated $4.36M.
- SEI Investments's ten largest holdings make up 18% of its $28.1B portfolio in Q4 2018.
- SEI Investments opened 180 new positions and closed 58 in Q4 2018.
- SEI Investments's portfolio value rose 1.8% quarter-over-quarter to $28.1B.
Based on SEI Investments's 13F filing for Q4 2018, filed 13 Feb 2019.